Company to Exhibit, Present Poster, and Speak on Regulatory Strategy Pitfalls in Diagnostic Development
San Diego, CA – DCN Dx, specializing in lateral flow diagnostics development and manufacturing and IVD regulatory consulting and clinical research, is excited to announce its participation in the 2025 Precision Med Tri-Conference & Expo, taking place March 11-13, 2025, at the Town & Country Resort in San Diego, California.
Visit DCN Dx at Booth 12
DCN Dx will exhibit at Booth 12, where attendees can learn more about the company’s comprehensive CDMO and CRO services tailored for the diagnostics industry. The team will be available to discuss how DCN Dx supports diagnostic developers with end-to-end solutions, from product development to clinical and regulatory support.
Patrick Vaughan, Ph.D., to Speak on Regulatory Pitfalls in Dx Development: Lessons from Real-World Case Studies
DCN Dx’s Chief Operating Officer, Patrick Vaughan, Ph.D., will deliver a presentation on Day 1, Tuesday, March 11, at 11:50 AM. Dr. Vaughan’s talk will explore a real-world STI biomarker lateral flow assay, highlighting common challenges and successful course corrections. He’ll examine the impact of early regulatory engagement, study design pitfalls, and the role of an experienced IVD CRO and CDMO partner in refining assays for validation, scalability, and commercialization in alignment with regulatory needs.
Poster Presentation: Navigating Regulatory Strategy in STI Dx Development: Lessons from a Dx Start-Up
Dr. Patrick Vaughan will also present a poster exploring the clinical validation of an STI biomarker lateral flow assay developed by a diagnostics start-up. The study highlights regulatory challenges, strategic adjustments, and the importance of early regulatory engagement and robust study design. The presentation emphasizes the role of an experienced IVD CRO and agile CDMO working together in refining assays and streamlining commercialization pathways.
Request a Meeting with DCN Dx
DCN Dx invites attendees to schedule a meeting during the event to discuss their lateral flow CDMO and IVD CRO needs. To request a meeting, click here.
About DCN Dx
DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research. DCN Dx’s multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory services.
DCN Dx’s personalized approach to IVD product development and clinical trials has supported hundreds of programs and clients. They can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, DCN Dx’s clinical research expertise extends to any in vitro diagnostic, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.
For more information contact:
Mitzi Rettinger
Chief Revenue Officer
DCN Dx
mrettinger@dcndx.com
(760) 804-3886
